Results 71 to 80 of about 272 (155)

Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. [PDF]

J Natl Cancer Inst, 2012
Amaral AF, Méndez-Pertuz M, Muñoz A, Silverman DT, Allory Y, Kogevinas M, Lloreta J, Rothman N, Carrato A, Rivas del Fresno M, Real FX, Malats N, Spanish Bladder Cancer/EPICURO Study investigators.   +12 more
europepmc   +1 more source

Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis. [PDF]

PLoS One, 2014
Pineda S, Milne RL, Calle ML, Rothman N, López de Maturana E, Herranz J, Kogevinas M, Chanock SJ, Tardón A, Márquez M, Guey LT, García-Closas M, Lloreta J, Baum E, González-Neira A, Carrato A, Navarro A, Silverman DT, Real FX, Malats N.   +19 more
europepmc   +1 more source

Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. [PDF]

Environ Health Perspect, 2013
Tajuddin SM, Amaral AF, Fernández AF, Rodríguez-Rodero S, Rodríguez RM, Moore LE, Tardón A, Carrato A, García-Closas M, Silverman DT, Jackson BP, García-Closas R, Cook AL, Cantor KP, Chanock S, Kogevinas M, Rothman N, Real FX, Fraga MF, Malats N, Spanish Bladder Cancer/EPICURO Study Investigators.   +20 more
europepmc   +1 more source

Genome-wide CNV analysis replicates the association between GSTM1 deletion and bladder cancer: a support for using continuous measurement from SNP-array data. [PDF]

BMC Genomics, 2012
Marenne G, Real FX, Rothman N, Rodríguez-Santiago B, Pérez-Jurado L, Kogevinas M, García-Closas M, Silverman DT, Chanock SJ, Génin E, Malats N.   +10 more
europepmc   +1 more source

Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence. [PDF]

Clin Epigenetics, 2015
Ruiz-Hernandez A, Kuo CC, Rentero-Garrido P, Tang WY, Redon J, Ordovas JM, Navas-Acien A, Tellez-Plaza M.   +7 more
europepmc   +1 more source

Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis. [PDF]

PLoS One, 2012
Czachorowski MJ, Amaral AF, Montes-Moreno S, Lloreta J, Carrato A, Tardón A, Morente MM, Kogevinas M, Real FX, Malats N, SBC/EPICURO investigators.   +10 more
europepmc   +1 more source

Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours. [PDF]

PLoS One, 2014
Vedder MM, Márquez M, de Bekker-Grob EW, Calle ML, Dyrskjøt L, Kogevinas M, Segersten U, Malmström PU, Algaba F, Beukers W, Ørntoft TF, Zwarthoff E, Real FX, Malats N, Steyerberg EW.   +14 more
europepmc   +1 more source

Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk. [PDF]

PLoS One, 2013
de Maturana EL, Ye Y, Calle ML, Rothman N, Urrea V, Kogevinas M, Petrus S, Chanock SJ, Tardón A, García-Closas M, González-Neira A, Vellalta G, Carrato A, Navarro A, Lorente-Galdós B, Silverman DT, Real FX, Wu X, Malats N.   +18 more
europepmc   +1 more source

Genetic susceptibility to distinct bladder cancer subphenotypes. [PDF]

Eur Urol, 2010
Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M, Rothman N, Vellalta G, Calle ML, Marenne G, Tardón A, Carrato A, García-Closas R, Serra C, Silverman DT, Chanock S, Real FX, Malats N, EPICURO/Spanish Bladder Cancer Study investigators.   +18 more
europepmc   +1 more source

Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study. [PDF]

Hum Mutat, 2011
Marenne G, Rodríguez-Santiago B, Closas MG, Pérez-Jurado L, Rothman N, Rico D, Pita G, Pisano DG, Kogevinas M, Silverman DT, Valencia A, Real FX, Chanock SJ, Génin E, Malats N.   +14 more
europepmc   +1 more source